Published in Vaccine Weekly, November 21st, 2001
"We used an oral immunization strategy with attenuated HCV-NS3-transformed Salmonella typhimurium to deliver DNA directly to the gut-associated lymphoid tissue," described H. Wedemeyer and coauthors in the November 2001 issue of Gastroenterology.
After murine immunization, Wedemeyer and colleagues collected and analyzed any detectable HCV epitope-specific CD8+ T cells, using...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.